Skip to main content

Table 5 clinical characteristics of PMN patients who detected circulating anti-PLA2R antibodies

From: The association between variants in PLA2R and HLA-DQA1 and renal outcomes in patients with primary membranous nephropathy in Western China

Characteristic

anti-PLA2R ( +)

anti-PLA2R (-)

P

Baseline

n = 91

n = 29

Age at biopsy (years)

51.07 ± 12.66

48.0 ± 15.63

0.172

Male (n, %)

57 (62.2)

15 (51.7)

0.296

Cr (μmol/L)

73.17 ± 25.05

75.60 ± 52.47

0.736

eGFR (ml/min/1.73 m2)

95.77 ± 21.78

100.84 ± 27.78

0.311

Urea (mmol/L)

6.17 ± 4.32

5.55 ± 2.71

0.472

Alb (g/L)

27.97 ± 26.29

27.7 ± 7.64

0.959

24 h-u-pro (g/d)

5.08 ± 3.55

4.36 ± 5.75

0.436

SBP (mmHg)

131.96 ± 15.16

127.89 ± 15.77

0.222

DBP (mmHg)

79.55 ± 10.68

78.39 ± 10.22

0.614